Essential Partners’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$58 Sell
4
-59
-94% -$1.01K ﹤0.01% 2756
2026
Q2
$1.34K Sell
63
-150
-70% -$2.82K ﹤0.01% 2114
2026
Q1
$3.72K Buy
213
+145
+213% +$2.88K ﹤0.01% 1721
2025
Q4
$1.33K Sell
68
-578
-89% -$12K ﹤0.01% 1933
2025
Q3
$17.8K Buy
+646
New +$19.9K 0.01% 933

Other funds holding USNA

Essential Partners's USNA Position: Q3 2026 in Review

Essential Partners reduced its Usana Health Sciences (USNA) stake by 94% in Q3 2026, selling an estimated $1.01K and leaving 4 shares worth $58. The position accounts for ﹤0.01% of the portfolio, ranked #2756.

Essential Partners first reported a position in USNA in Q3 2025 and has held it in 5 quarters since. The position peaked at $17.8K in Q3 2025. 6 funds tracked by Wall St. Rank hold USNA as of Q3 2026.

  • Essential Partners held 4 shares of Usana Health Sciences worth $58 as of Q3 2026.
  • Essential Partners sold 59 Usana Health Sciences shares in Q3 2026, an estimated $1.01K.
  • Usana Health Sciences made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2756 holding.
  • Essential Partners first reported a position in Usana Health Sciences in Q3 2025 and has held it in 5 quarters since.
  • Essential Partners's Usana Health Sciences position peaked at $17.8K in Q3 2025.
  • 6 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.